Early response and 8-week treatment outcome in GAD

Depression and Anxiety

Volumn 23, Issue 8, 2006, Pages 461-465

  Rynn, Moira ^a,b   Khalid Khan, Sarosh ^a   Garcia Espana, J Felipe ^a   Etemad, Bijan ^a   Rickels, Karl ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE   (United States)

Author keywords

5HT 1A partial agonist; Diazepam; Early onset; GAD; Improvement; Placebo

Indexed keywords

BENZODIAZEPINE; DIAZEPAM; FLESINOXAN; GEPIRONE; PLACEBO; SEROTONIN AGONIST;

ADULT; ANALYSIS OF COVARIANCE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EVALUATION; FEMALE; GENERALIZED ANXIETY DISORDER; HAMILTON ANXIETY SCALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; DIAZEPAM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PYRIMIDINES; RANDOMIZED CONTROLLED TRIALS; SEROTONIN AGONISTS; TREATMENT OUTCOME;

EID: 33845498669     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20214     Document Type: Article

References (24)

1. Albus M, Lecrubier Y, Maier W, Buller R, Rosenberg R, Hippius H. 1990. Drug treatment of panic: Early response to treatment as predictor of final outcome. Acta Psychiatr Scand 82:359-365.
2. Ballenger JC. 1999. Clinical guidelines for establishing remission in patients with depression and anxiety. J Clin Psychiatry 60:29-34.
3. Coryell W, Coppen A, Zeigler VE, Biggs JT. 1982. Early improvement as a predictor of response to amitriptyline and nortriptyline: A comparison of 2 patient samples. Psychol Med 12:135-139.
4. Crits-Christoph P, Connolly MB, Gallop R, Barber JP, Tu X, Gladis M, Siqueland L. 2001. Early improvement during manual-guided cognitive and dynamic psychotherapies predicts 16 week remission status. J Psychother Pract Res 10:145-154.
5. Downing RW, Rickels K. 1985. Early treatment response in anxious outpatients treated with diazepam. Acta Psychiatr Scand 72: 522-528.
6. Fink E, Braden W, Qualis CB. 1982. Predicting pharmacotherapy outcome by subjective response. J Clin Psychiatry 43:272-275.
7. Guy W, editor. 1976. ECDEU assessment manual for psychopharmacology, revised [DHEW Pub. No. (ADM) 76-338]. Rockville, MD: National Institute of Mental Health.
8. Hamilton MA. 1959. The assessment of anxiety status by rating. Br J Med Psychol 32:50-55.
9. Harvey PD, Davidson M, Powchik P, Schmeidler J, McQueeney R, Kaminsky R, Davis KL. 1991. Time course and clinical predictors of treatment response in schizophrenia. Schizophrenia Res 5:161-166.
10. Kirtner WL, Cartwright DS. 1958. Success and failure in client centered therapy as a function of initial in-therapy behavior. J Consult Clin Psychol 22:329-333.
11. May PRA, van Putten T, Yale C. 1980. Predicting outcome of antipsychotic drug treatment from early response. Am J Psychiatry 137:1088-1089.
12. Mitchell PB, Schweitzer I, Burrows G, Johnson G, Polonowita A. 2000. Efficacy of venlafaxine and predictors of response in a prospective open-label study of patients with treatment-resistant major depression. J Clin Psychopharmacol 20:483-487.
13. Montgomery SA, Montgomery DB, Finberg N. 1990. Early response with clomipramine in obsessive compulsive disorder-a placebo controlled study. Prog Neuropsychophamacol Biol Psychiatry 14:719-727.
14. Nierenberg AA, Farabaugh AH, Alpert JE, Gordon J, Worthington JJ, Rosenbaum JF, Fava M. 2000. Timing of onset of antidepressant response with fluoxetine treatment. Am J Psychiatry 157:1423-1428.
15. Nierenberg AA, McLean NE, Alpert JE, Worthington JJ, Rosenbaum JF, Fava M. 1995. Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry 152:1500-1503.
16. Pollack MH, Rapaport MH, Otto MW, Fayyad R, Otto MW, Nierenberg AA, Clary CM. 2002. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder. J Psychiatr Res 36:229-236.
17. Quitkin FM, McGrath PJ, Stewart JW, Taylor BP, Klein DF. 1996. Can the effects of antidepressants be observed in the first two weeks of treatment? Neuropsychopharmacology 15:390-394.
18. Rickels K, Schweizer E, DeMartinis N, Mandos L, Mercer C. 1997. Gepirone and diazepam in generalized anxiety disorder: A placebo-controlled trial. J Clin Psychopharmacol 17:272-277.
19. Ruther E. 1981. Initial improvement as predictor of outcome of neuroleptic treatment. Pharmacopsychiatry 14:205-207.
20. SAS Institute, Inc. 2000. SAS/STAT User's Guide, version 8. Cary, NC: Author.
21. Schweizer E, Rickels K, Amsterdam JD, Fox I, Puzzuoli G, Weise C. 1990. What constitutes an adequate antidepressant trial for fluoxetine? J Clin Psychiatry 51:8-11.
22. Stern RG, Kahn RS, Davidson M, Nora RM, Davis KL. 1994. Early response to clozapine in schizophrenia. Am J Psychiatry 151:1817-1818.
23. Stern RG, Kahn RS, Harvey PD, Amin F, Apter SH, Hirschowitz J. 1993. Early response to haloperidol treatment in chronic schizophrenia. Schizophrenia Res 10:165-171.
24. Szegedi A, Müller MJ, Anghelescu I, Klawe C, Kohnen R, Benkert O. 2003. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patient with major depression. J Clin Psychiatry 64:413-420.